NVAX

Conviction 82HealthcareScan · Thu, Sep 24, 2026

Novavax Inc (NVAX) closed at $10.60 (+0.47%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 88, -5.3% from its 52-week high, +48.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

NVAX$10.60+0.47%

ResistanceSupportVol 14

Vol MA14 5.89M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

NOVAVAX INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.novavax.com ↗

Price10.60

Change+0.47%

Gap-0.57%

Rel volume1.31×

Avg volume5.96M

Avg $ vol59.61M

SMA 209.91

SMA 508.78

SMA 2008.77

Price vs 50+20.79%

Price vs 200+20.92%

MA stackbullish

50/200 crossgolden · 0d

Supertrendup · 8.92

RSI (14)64

MACD hist0.06

MACD crossbull · 3d

Stoch %K / %D75 / 78

ADX (14)39

+DI / −DI32 / 10

RSI divergence—

MACD divergence—

ATR %5.36%

ADR %5.88%

52w high11.19

52w low6.22

From 52w high-5.27%

Above 52w low+70.42%

New 52w highNo

SqueezeOff

Bollinger width21.27%

%B0.83

Donchian pos77.73%

Donchian high11.09

Donchian low8.89

AVWAP (52w high)9.32

vs AVWAP high+13.71%

AVWAP (52w low)8.96

vs AVWAP low+18.28%

OBV trendUp

Chaikin MF (20)0.10

Today vs 20d1.31×

Avg vol (14d)5.89M

Avg vol (20d)5.96M

Avg $ vol (20d)59.61M

Market cap1.75B

RS Rating88 / 99

RS 3m (vs SPY)+19.34%

RS 6m (vs SPY)-3.33%

RS line new highNo

Trend template7/8

Technical rank89.1

1 week+6.00%

1 month+12.29%

3 months+23.83%

6 months+13.49%

1 year+22.26%

YTD+48.67%

P/E3.97

P/B-9.17

P/S1.56

P/FCF—

EPS2.58

Div yield—

ROE-230.88%

ROA46.08%

Debt/Eq-1.53

Current2.33

EV/EBITDA3.85

Gross margin—

Net margin39.19%

Rev growth64.69%

EPS growth334.83%

Price target11.33

Target upside6.89%

Analyst ratingBuy

Institutional80.69%

Ent. value1.85B

Revenue56.7M

Net income-53.39M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out164.44M

Employees749

ListedTue, Dec 5, 1995

Free float154.66M

Float %94.9%

Short interest48.78M

Days to cover8.6d

Short volume48.7%

Squeeze score76 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.32 vs −$0.36

Last surprise+11.1% beat

Setup gradeA

Conviction82 / 100

Pattern quality—

Tech rank89.1 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.92

Support8.36

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NVAX

All disclosures →

No recent disclosed trades by Congress in NVAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NVAX

Insider	Side	Shares	Value	Traded	Filed
Newton Charles W. Director · Common Stock · 2026-04-25	Exercise	9.52K	$0	2026-04-25	2026-04-28
Newton Charles W. Director · Restricted Stock Units · 2026-04-25	Exercise	9.52K	$0	2026-04-25	2026-04-28
Walker Robert Edward EVP, R&D · Restricted Stock Units · 2026-04-14	Grant	66K	$0	2026-04-14	2026-04-16
Walker Robert Edward EVP, R&D · Stock Option (Right to Buy) · 2026-04-14	Grant	99.5K	$0	2026-04-14	2026-04-16

SEC filings

EDGAR filings in NVAX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.